https://orcid.org/0000-0002-9740-6300
References
- Adnan N, Boland F, Murphy DJ. Intramuscular Oxytocin versus intravenous Oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial. Trials. 2017;18(1):541. doi:10.1186/s13063-017-2269-9
- Balki M, Erik-Soussi M, Kingdom J, Carvalho JC. Comparative efficacy of uterotonic agents: in vitro contractions in isolated myometrial strips of labouring and non-labouring women. Can J Anaesth. 2014;61(9):808–818. doi:10.1007/s12630-014-0190-1.
- Yaliwal R, Bidri S, Navani A. A randomized controlled trial of sublingual Misoprostol - 600µg versus intravenous Oxytocin - 10IU in prevention of post partum hemorrhage during cesarean section. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019;8(10):3865–3869. doi:10.18203/2320-1770.ijrcog20194206
- Charles D, Anger H, Dabash R. Intramuscular injection, intravenous infusion, and intravenous bolus of Oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial. BMC Pregnancy Childbirth. 2019;19:38. doi:10.1186/s12884-019-2181-2
- Derbel M, Mekki D, Riahi A, Dimassi K, Mebazaa MS, Gara MF. Comparison of two Oxytocin administration protocols in elective cesarean section: 5iu versus 10 iu. Tunis Med. 2016;94(4):253–258.
- Butwick* J, Coleman L, Cohen SE, Riley ET, Carvalho B. Cohen et al Minimum effective bolus dose of Oxytocin during elective Caesarean delivery. Br J Anaesth. 2010;104(3):338–343. doi:10.1093/bja/aeq004
- Stephens LC, Bruessel T. Systematic review of Oxytocin dosing at caesarean section. Anaesth Intensive Care. 2012;40(2):247–252. doi:10.1177/0310057X1204000206
- Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of Oxytocin in the third stage of labor. Cochrane Database Syst Rev. 2001;4:CD001808.
- Lokugamage AU, Paine M, Bassaw Balroop K, Sullivan KR, Refaey HE, Rodeck CH. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon. Aust N Z J Obstet Gynaecol. 2001;41:411–414. doi:10.1111/j.1479-828X.2001.tb01319.x
- Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. Comparison of two Oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2001;98:386–390.
- National Collaborating Centre for Women’s and Children’s Health. Caesarean section. Clinical Guideline. 2004. RCOG Press.
- Cotter A, Ness A, Tolosa J. Prophylactic Oxytocin for the third stage of labor. Cochrane Database Syst Rev. 2001;4:CD001808.
- Begley CM, Gyte GM, Murphy DJ, Devane D, McDonald SJ, McGuire W. Active versus expectant management for women in the third stage of labor. Cochrane Database Syst Rev. 2010;7:CD007412.
- Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R, Geary M, Murphy DJ; ECSSIT Study Group. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343:d4661. doi:10.1136/bmj.d4661.
- Mockler JC, Murphy DJ, Wallace EM. An Australian and New Zealand survey of practice prendiville, W.O.C., M., Active management of the third stage of labor. In: C B, L L, G K, A B, L M, Karoshi, editors. A Textbook of Postpartum Hemorrhage. 1ed ed. Duncow: sapiens publishing; 2006:462.
- Gibbens D, Boyd NRH, Crocker S, et al. The circulating levels of Oxytocin following intravenous and intramuscular administration of Syntometrine. J Obstet Gynaecol Br Commonw. 1972;79(7):644–646. doi:10.1111/j.1471-0528.1972.tb14215.x
- Breathnach F, Geary M. Standard medical therapy. In: B-Lynch C, Keith LG, Lalonde AB, aroshi M, editors. A Textbook of Postpartum Hemorrhage: A Comprehensive Guide to Evaluation, Management and Surgical Intervention. 1st edn ed. Duncow, Kirkmahoe, Dumfriesshire, UK: Sapiens Publishing; 2006.
- Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of Oxytocin given as i.V. Bolus or infusion on women undergoing caesarean section. Br J Anaesth. 2007;98(1):116–9. 256–262. doi:10.1093/bja/ael302
- Schulz KF, Altman DG, Moher D. Updated Guidelines for Reporting Parallel Group Randomised Trials. PLoS Med. 2010;7(3):e1000251. https://journals.plos.org/plosmedicine/article.
- Tandon R, Khan TA, Mehrotra S. Oxytocin given as IV bolus versus IV infusion in women undergoing caesarean section- a randomised, controlled, double-blind study. J Evolution Med Dent Sci. 2018;7(11):1423–1425. doi:10.14260/jemds/2018/323
- Mathe P, Kale S, Batra A, Batra A, Aggrawal S, Nagarajappa A. Intravenous Oxytocin bolus and infusion versus infusion alone on the blood loss during caesarean section. Int J Reprod Contracept Obstet Gynecol. 2019;8:4824–4828. doi:10.18203/2320-1770.ijrcog20195328